2006 Midyear Clinical Meeting
Click here to go to the previous page
Therapeutic Debates in Special Patient Populations
Track:
Sessions
Program Code: 283-L01
Date: Thursday, December 7, 2006
Time: 9:00 AM to 12:00 PM
Location:
210B (CC)
MODERATOR:
Dr. Edith Nutescu, PharmD, FCCP, Clinical Associate Professor and Director, Antithrombosis Center, University of Illinois at Chicago, College of Pharmacy
SPEAKER(S):
Stuart Haines, Pharm.D., FCCP, FASHP, FAPha, Professor and Vice Chair of Education, University of Maryland School of Pharmacy, Clinical Associate Professor of Medicine, University of Maryland School of Medicine, Baltimore, Maryland
Con: Slow and Gentle Treatment is Needed [Treating Dyslipidemias in Older Adults]
Kristin C. Klein, Pharm.D., Clinical Assistant Professor, University of Michigan College of Pharmacy, Ann Arbor
Pro: Childhood Immunizations are Necessary [The Importance of Complying with a Comprehensive Immunization Program in Pediatric Patients]
Sherry A. Luedtke, PharmD
Dr. Luedtke is Associate Professor of Pharmacy Practice and Associate Dean of Professional Affairs at Texas Tech University Health Sciences Center School of Pharmacy in Amarillo, Texas. She received her Doctor of Pharmacy degree from the University of Wisconsin and completed her Pediatric Specialty Resident at the University of Kentucky. Dr. Luedtke has given numerous presentations in the areas neonatal drug therapy and has received several practice awards for innovative practice in pediatrics. She has been strongly involved in professional organizations supporting pediatric pharmacotherapy including service as a Past President of the Pediatric Pharmacy Advocacy Group (PPAG) and service as their Executive VP of Advocacy.
|
Con: Childhood Immunizations are Not Necessary [The Importance of Complying with a Comprehensive Immunization Program in Pediatric Patients]
Eric MacLaughlin,
PharmD, BCPS, Associate Professor and Division Head of Adult Medicine,
Texas Tech School of Pharmacy
Eric MacLaughlin, Pharm.D., FCCP, BCPS is an Associate Professor and Division Head of Adult Medicine, Department of Pharmacy Practice at Texas Tech School of Pharmacy. He is also a Clinical Pharmacist with the Department of Family Medicine at Texas Tech School of Medicine. He received his B.S. in Pharmacy from Albany College of Pharmacy, Pharm.D. from the Medical University of South Carolina, and completed a Primary Care Specialty Residency at the University of Colorado. His practice interests include family medicine and outpatient geriatrics. Research interests include the treatment of hypertension, screening and treatment of osteoporosis, and pharmacy education.
|
Pro: Aggressive Osteoporosis Prevention Should be Promoted [The Need for Promoting Aggressive Osteoporosis Prevention Options in Elderly Patients]
Dr. Saseen is an Associate Professor of Clinical Pharmacy and Family Medicine at the University of Colorado Denver. He is a Board Certified Pharmacotherapy Specialist with added qualifications in cardiology, is certified as a Clinical Lipid Specialist, and is a Fellow of the American College of Clinical Pharmacy. Dr. Saseen received both his B.S. pharmacy degree and PharmD degree from the State University of New York at Buffalo and then completed an ambulatory care research fellowship at the University of Illinois at Chicago. In his current position, Dr. Saseen practices as a clinical pharmacy specialist at University of Colorado’s Family Medicine Center, and educates pharmacy and medical students. His research and other scholarly endeavors focus on cardiovascular pharmacotherapy. Dr. Saseen is on the board of regents for the American College of Clinical Pharmacy, is a member of the Board of Directors for the National Lipid Association’s Accreditation Council for Clinical Lipidology, and is a member of the Board of Directors and Editorial Board for the journal Pharmacotherapy. He has won several teaching awards, most recently was the recipient of the Doctor of Pharmacy Class of 2009’s Outstanding Instructor Award in May of 2008.
|
Pro: Early and Aggressive Treatment is Needed [Treating Dyslipidemias in Older Adults]
Pamela L. Stamm, Pharm.D., Associate Professor, Pharmacy Practice, James I. Harrison School of Pharmacy, Auburn University, AL
Con: Aggressive Osteoporosis Prevention Should Not be Promoted [The Need for Promoting Aggressive Osteoporosis Prevention Options in Elderly Patients]
Description
Learning Objectives:
Identify target lipid lowering goals in geriatric patients with hypercholesterolemia. Describe the need and the importance of timely and comprehensive immunizations in pediatric patients. Describe the benefit of aggressive osteoporosis prevention protocols and treatment programs for elderly patients.